The SNPs from the other four genes (ACTA2, AGPHD1, SEC14L5, and RBMS3) included in this study did not reach any statistically significant association with lung cancer risks or cisplatin based chemotherapy response in our study population. Here, ACTA2 is linked to lung carcinoma.